206 related articles for article (PubMed ID: 24704616)
1. Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORγ inhibitors using virtual screening, synthesis and biological evaluation.
Zhang Y; Xue X; Jin X; Song Y; Li J; Luo X; Song M; Yan W; Song H; Xu Y
Eur J Med Chem; 2014 May; 78():431-41. PubMed ID: 24704616
[TBL] [Abstract][Full Text] [Related]
2. Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
Song Y; Xue X; Wu X; Wang R; Xing Y; Yan W; Zhou Y; Qian CN; Zhang Y; Xu Y
Eur J Med Chem; 2016 Jun; 116():13-26. PubMed ID: 27043267
[TBL] [Abstract][Full Text] [Related]
3. Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds.
Zhang W; Zhang J; Fang L; Zhou L; Wang S; Xiang Z; Li Y; Wisely B; Zhang G; An G; Wang Y; Leung S; Zhong Z
Mol Pharmacol; 2012 Oct; 82(4):583-90. PubMed ID: 22700697
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a cell-based assay for the nuclear receptor retinoid-related orphan receptor gamma.
Wilkinson J; Hallis T; Hermanson S; Bi K
Assay Drug Dev Technol; 2011 Apr; 9(2):125-35. PubMed ID: 21050030
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist.
Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H
J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388
[TBL] [Abstract][Full Text] [Related]
6. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α.
Doebelin C; He Y; Campbell S; Nuhant P; Kumar N; Koenig M; Garcia-Ordonez R; Chang MR; Roush WR; Lin L; Kahn S; Cameron MD; Griffin PR; Solt LA; Kamenecka TM
Med Chem; 2019; 15(6):676-684. PubMed ID: 30799793
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor Activity.
Lu B; Liu D; Gui B; Gou J; Dong H; Hu Q; Feng J; Mao Y; Shen X; Wang S; Zhang C; Shen R; Yan Y; Chen L; Wang H; Li D; Zhang J; Zhang M; Zhang R; Bai C; He F; Tao W; Liu S
J Med Chem; 2021 Oct; 64(20):14983-14996. PubMed ID: 34643383
[TBL] [Abstract][Full Text] [Related]
9. The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT.
Karaś K; Sałkowska A; Karwaciak I; Walczak-Drzewiecka A; Dastych J; Bachorz RA; Ratajewski M
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744223
[TBL] [Abstract][Full Text] [Related]
10. Identification of tertiary sulfonamides as RORc inverse agonists.
Fauber BP; René O; Burton B; Everett C; Gobbi A; Hawkins J; Johnson AR; Liimatta M; Lockey P; Norman M; Wong H
Bioorg Med Chem Lett; 2014 May; 24(9):2182-7. PubMed ID: 24685544
[TBL] [Abstract][Full Text] [Related]
11. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
[TBL] [Abstract][Full Text] [Related]
13. Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).
Fauber BP; Magnuson S
J Med Chem; 2014 Jul; 57(14):5871-92. PubMed ID: 24502334
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.
Sun N; Ma X; Zhou K; Zhu C; Cao Z; Wang Y; Xu J; Fu W
Eur J Med Chem; 2020 Feb; 187():111984. PubMed ID: 31881455
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide analogs as new RORC modulators.
Muegge I; Collin D; Cook B; Hill-Drzewi M; Horan J; Kugler S; Labadia M; Li X; Smith L; Zhang Y
Bioorg Med Chem Lett; 2015 May; 25(9):1892-5. PubMed ID: 25840886
[TBL] [Abstract][Full Text] [Related]
16. Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions.
Shaikh NS; Iyer JP; Munot YS; Mukhopadhyay PP; Raje AA; Nagaraj R; Jamdar V; Gavhane R; Lohote M; Sherkar P; Bala M; Petla R; Meru A; Umrani D; Rouduri S; Joshi S; Reddy S; Kandikere V; Bhuniya D; Kulkarni B; Mookhtiar KA
Bioorg Med Chem Lett; 2019 Aug; 29(16):2208-2217. PubMed ID: 31272795
[TBL] [Abstract][Full Text] [Related]
17. Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses.
Pandya VB; Kumar S; Sachchidanand ; Sharma R; Desai RC
J Med Chem; 2018 Dec; 61(24):10976-10995. PubMed ID: 30010338
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel N-sulfonamide-tetrahydroisoquinolines as potent retinoic acid receptor-related orphan receptor γt agonists.
Ma X; Sun N; Li X; Fu W
Eur J Med Chem; 2021 Oct; 222():113585. PubMed ID: 34118722
[TBL] [Abstract][Full Text] [Related]
19. Discovery of biaryls as RORγ inverse agonists by using structure-based design.
Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD
Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181
[TBL] [Abstract][Full Text] [Related]
20. Sulfoximines as potent RORγ inverse agonists.
Ouvry G; Bihl F; Bouix-Peter C; Christin O; Defoin-Platel C; Deret S; Feret C; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Lafitte G; Luzy AP; Musicki B; Orfila D; Parnet V; Pascau C; Pascau J; Pierre R; Raffin C; Rossio P; Spiesse D; Taquet N; Thoreau E; Vatinel R; Vial E; Hennequin LF
Bioorg Med Chem Lett; 2018 May; 28(8):1269-1273. PubMed ID: 29571573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
